You are here

Article metrics

Article menu

Download PDFPDF

Poster Presentation
A phase I study of an agonist anti-CD27 human antibody (CDX-1127) in patients with advanced hematologic malignancies or solid tumors

 

Online download statistics by month:

Online download statistics by month: December 2019 to February 2026

AbstractFullPdf
Dec 2019010
Jan 2020031
Feb 2020031
Apr 2020011
May 2020050
Jun 202001510
Jul 2020030
Aug 2020020
Sep 20200121
Oct 2020020
Dec 2020030
Jan 2021010
Feb 2021011
Mar 2021021
Apr 2021020
May 20210100
Jun 20210100
Jul 2021020
Sep 2021010
Oct 2021043
Nov 2021051
Dec 20210102
Jan 2022081
Feb 20220111
Mar 20220152
Apr 20220172
May 20220267
Jun 20220233
Jul 20220171
Aug 20220122
Sep 20220268
Oct 20220212
Nov 20220308
Dec 20220211
Jan 20230233
Feb 20230590
Mar 2023082
Apr 2023021
May 2023011
Jun 2023010
Jul 2023023
Aug 2023011
Sep 2023042
Oct 2023032
Nov 20230161
Dec 2023068
Jan 20240131
Feb 2024031
Mar 2024081
Apr 2024072
May 2024020
Jun 2024083
Jul 2024091
Aug 2024052
Sep 2024065
Oct 2024055
Nov 2024072
Dec 2024022
Jan 20250916
Feb 2025041
Mar 2025038
Apr 20250151
May 20250413
Jun 20250107
Feb 2026010
Total0708145